SCHEMBL327482

SCHEMBL327482

COc1ccc(-c2ccc3nc(N)nc(-c4ccc(C([NH])=O)cc4)c3c2)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.45
DHFR P00374 1/20 0.44
ADORA2A P29274 1/20 0.43
CHEK1 O14757 1/20 0.43
CHEK2 O96017 1/20 0.43
HSP90AB1 P08238 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
NEK2 P51955 1/20 0.41
WHR1 P49842 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PIK3CD O00329 3/20 0.40
PIK3CA P42336 3/20 0.40
PIK3CB P42338 3/20 0.40
PIK3CG P48736 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL182822 0.91 CHEK2 (0.53) ADORA1DHFRADORA2ACHEK1CHEK2
SCHEMBL182850 0.85 DHFR (0.53) ADORA1DHFRADORA2AHSP90AB1L3MBTL1
SCHEMBL1883143 0.83 MAPT (0.51) ADORA1DHFRADORA2AL3MBTL1KDM4E
SCHEMBL182897 0.81 ADORA1 (0.48) ADORA1DHFRADORA2AHSP90AB1L3MBTL1
SCHEMBL188522 0.81 DHODH (0.52) ADORA1DHFRADORA2AL3MBTL1NEK2
SCHEMBL182575 0.81 ADORA1 (0.52) ADORA1DHFRADORA2AHSP90AB1L3MBTL1
SCHEMBL183022 0.80 SQSTM1 (0.48) ADORA1DHFRADORA2AHSP90AB1L3MBTL1
SCHEMBL182874 0.79 PDGFRB (0.48) ADORA1DHFRADORA2AHSP90AB1L3MBTL1
SCHEMBL183072 0.78 FYN (0.54) ADORA1DHFRADORA2AL3MBTL1PIK3CD
SCHEMBL182810 0.77 PIK3CA (0.49) ADORA1DHFRADORA2AHSP90AB1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049502-B1 2,4-SUBSTITUTED QUINAZOLINES AS LIPID KINASE INHIBITORS NOVARTIS AG (CH) 2012-01-04 EP claimed